181 related articles for article (PubMed ID: 37312186)
1. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
Sun X; Zhang J; Hu J; Han Q; Ge Z
BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
[TBL] [Abstract][Full Text] [Related]
2. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
Sun X; Zhang J; Xiao C; Ge Z
BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
[TBL] [Abstract][Full Text] [Related]
3. GBP2 Is a Favorable Prognostic Marker of Skin Cutaneous Melanoma and Affects Its Progression via the Wnt/β-catenin Pathway.
Ji G; Luo B; Chen L; Shen G; Tian T
Ann Clin Lab Sci; 2021 Nov; 51(6):772-782. PubMed ID: 34921030
[TBL] [Abstract][Full Text] [Related]
4. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
[TBL] [Abstract][Full Text] [Related]
5. α-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma.
Zhang K; Tian R; Zhang W; Li Y; Zeng N; Liang Y; Tang S
Mol Biol Rep; 2022 Sep; 49(9):8241-8250. PubMed ID: 35925486
[TBL] [Abstract][Full Text] [Related]
6. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.
Zhang W; Xie X; Huang Z; Zhong X; Liu Y; Cheong KL; Zhou J; Tang S
Front Immunol; 2022; 13():919145. PubMed ID: 36211371
[TBL] [Abstract][Full Text] [Related]
7. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
[TBL] [Abstract][Full Text] [Related]
8. KIF4A functions as a diagnostic and prognostic biomarker and regulates tumor immune microenvironment in skin cutaneous melanoma.
Zeng S; Wang Q; Zhou R; Wang D
Pathol Res Pract; 2024 Feb; 254():155166. PubMed ID: 38286055
[TBL] [Abstract][Full Text] [Related]
9. FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma.
Cai Z; Duan Y; Li W; Liu Z; Gong Z; Hong S; He X; Xuanyuan X; Chen Y; Bi X; Wang W
Front Immunol; 2023; 14():1295831. PubMed ID: 38077326
[TBL] [Abstract][Full Text] [Related]
10. Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments.
Bai R; Yin P; Xing Z; Wu S; Zhang W; Ma X; Gan X; Liang Y; Zang Q; Lei H; Wei Y; Zhang C; Dai B; Zheng Y
Apoptosis; 2024 Apr; 29(3-4):372-392. PubMed ID: 37945816
[TBL] [Abstract][Full Text] [Related]
11. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
12. SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients.
Pang H; Zhou Y; Wang J; Wu H; Cui C; Xiao Z
Transl Oncol; 2022 Jan; 15(1):101253. PubMed ID: 34737118
[TBL] [Abstract][Full Text] [Related]
13. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the role of wound healing genes in skin cutaneous melanoma: Insights into expression, methylation, mutations, and therapeutic implications.
Zhang Y; Gao C; Luo J; Khan A; Salem-Bekhit MM; Salem MM; Qi Z; Jiang B
Int Wound J; 2024 Apr; 21(4):e14807. PubMed ID: 38591163
[TBL] [Abstract][Full Text] [Related]
15. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
16. Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma.
Song B; Wang K; Peng Y; Zhu Y; Cui Z; Chen L; Yu Z; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18135-18160. PubMed ID: 38006451
[TBL] [Abstract][Full Text] [Related]
17. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
19. Identification of sterile a-motif domain-containing 9-like as a potential biomarker in patients with cutaneous melanoma.
Ye J; Tang H; Xie C; Han W; Shen G; Qian Y; Xu J
PeerJ; 2023; 11():e15634. PubMed ID: 37426410
[TBL] [Abstract][Full Text] [Related]
20. HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma.
He S; Ding Y; Ji Z; Yuan B; Chen J; Ren W
Cancer Cell Int; 2023 Jun; 23(1):122. PubMed ID: 37344870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
